Skip to main content
. 2023 Jan 23;177(4):384–394. doi: 10.1001/jamapediatrics.2022.6243

Figure 2. Forest Plots Showing the Odds Ratio (OR) of Efficacy Outcomes Following the Second Dose of Messenger RNA (mRNA) Vaccine.

Figure 2.

Two-dose mRNA COVID-19 vaccination was associated with lower risks of SARS-CoV-2 infections with or without symptoms, symptomatic SARS-CoV-2 infections, hospitalizations due to COVID-19–related illnesses, and multisystem inflammatory syndrome in children. ORs were calculated using random-effects model. IV indicates inverse variance.